Pages that link to "Q22242669"
Jump to navigation
Jump to search
The following pages link to Tuberculosis vaccines: beyond bacille Calmette-Guerin (Q22242669):
Displaying 50 items.
- Vaccines for low-income countries (Q26824128) (← links)
- Vaccine development for tuberculosis: current progress (Q26827737) (← links)
- Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosis (Q26863391) (← links)
- Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium (Q26865560) (← links)
- Prime-boost approaches to tuberculosis vaccine development (Q27024526) (← links)
- Tackling tuberculosis: Insights from an international TB Summit in London (Q28602294) (← links)
- Interpreting measures of tuberculosis transmission: a case study on the Portuguese population. (Q31166349) (← links)
- Multidrug resistant tuberculosis: A challenge in clinical orthopedics (Q33735674) (← links)
- Vaccines against poverty (Q34119892) (← links)
- History of BCG Vaccine. (Q34370165) (← links)
- Oral vaccination with lipid-formulated BCG induces a long-lived, multifunctional CD4(+) T cell memory immune response (Q34438532) (← links)
- Update on cutaneous tuberculosis (Q34504457) (← links)
- Recent Advances in Defining the Immunoproteome of Mycobacterium tuberculosis (Q35018134) (← links)
- Secretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs (Q35035800) (← links)
- The role of B cells and humoral immunity in Mycobacterium tuberculosis infection (Q35039807) (← links)
- Immunology studies in non-human primate models of tuberculosis (Q35116998) (← links)
- Vaccines and global health (Q35137116) (← links)
- DNA-Launched Alphavirus Replicons Encoding a Fusion of Mycobacterial Antigens Acr and Ag85B Are Immunogenic and Protective in a Murine Model of TB Infection (Q35758746) (← links)
- Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis (Q35896225) (← links)
- Gene expression profiling identifies candidate biomarkers for active and latent tuberculosis (Q35906290) (← links)
- HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice (Q36079913) (← links)
- Protection associated with a TB vaccine is linked to increased frequency of Ag85A-specific CD4(+) T cells but no increase in avidity for Ag85A (Q36096965) (← links)
- Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months. (Q36154690) (← links)
- Diterpenes as lead molecules against neglected tropical diseases. (Q36206465) (← links)
- Kinetics of IFN-gamma and TNF-alpha gene expression and their relationship with disease progression after infection with Mycobacterium tuberculosis in guinea pigs (Q36793138) (← links)
- Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines (Q36849770) (← links)
- Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malaria (Q36981626) (← links)
- Recombinant vaccines and the development of new vaccine strategies. (Q37370940) (← links)
- Mycobacterial L-forms are found in cord blood: A potential vertical transmission of BCG from vaccinated mothers (Q37375946) (← links)
- Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape. (Q37455406) (← links)
- Integrative immunoinformatics for Mycobacterial diseases in R platform (Q37601159) (← links)
- Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology (Q38031924) (← links)
- Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines (Q38059150) (← links)
- Immunology and world health: key contributions from the global community (Q38079607) (← links)
- Tuberculous meningitis: more questions, still too few answers (Q38131175) (← links)
- Rhodococcus equi (Prescottella equi) vaccines; the future of vaccine development. (Q38221560) (← links)
- Key issues in the clinical development and implementation of TB vaccines in South Africa (Q38415782) (← links)
- Emerging drugs and alternative possibilities in the treatment of tuberculosis (Q38724073) (← links)
- A major event for new tuberculosis vaccines (Q38980710) (← links)
- Modelling the cost-effectiveness of a new infant vaccine to prevent tuberculosis disease in children in South Africa (Q39125505) (← links)
- Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice (Q39202380) (← links)
- Duration of BCG protection against tuberculosis and change in effectiveness with time since vaccination in Norway: a retrospective population-based cohort study (Q39302030) (← links)
- Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status (Q39395640) (← links)
- Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis (Q40006239) (← links)
- Vaccine research and development: tuberculosis as a global health threat (Q40059597) (← links)
- Role and contribution of pulmonary CD103+ dendritic cells in the adaptive immune response to Mycobacterium tuberculosis (Q40382190) (← links)
- Dendritic Cell Activity Driven by Recombinant Mycobacterium bovis BCG Producing Human IL-18, in Healthy BCG Vaccinated Adults (Q41015596) (← links)
- Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines (Q42253606) (← links)
- Addressing the Challenges of Tuberculosis: A Brief Historical Account (Q42369869) (← links)
- Genetically attenuated Trypanosoma cruzi parasites as a potential vaccination tool (Q42412311) (← links)